Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients
AssigneeNexBio, Inc.
InventorsRonald D. Moss, Tiejun Li
Life of this patent
Estimating the term…
Abstract
A method of reducing or treating parainfluenza or influenza virus infection in an immunocompromised patient by administering to the respiratory tract of the patient a composition comprising a therapeutically effective amount of protein having sialidase activity.
Claims46
A method of treating a patient, the method comprising administering to the respiratory tract of the patient a liquid composition comprising a therapeutically effective amount of polypeptide having sialidase activity.
A method of reducing or treating parainfluenza or influenza virus infection in an immunocompromised patient, the method comprising administering to the respiratory tract of the patient a composition comprising a therapeutically effective amount of protein having sialidase activity.
A method of treating an immunocompromised patient at risk for infection with parainfluenza or influenza virus, the method comprising administering to the respiratory tract of the patient a therapeutically effective amount of protein having sialidase activity.
A method for reducing the viral load of PIV in a patient suffering from PIV infection, the method comprising administering to the patient a composition comprising DAS181.
A method for improving lung function in a patient suffering from PIV infection, the method comprising administering to the patient a composition comprising DAS181.
Dependencies are inferred from the claim text.